All In Biotech

Drug Trial Radar · NCT06268054

Efficacy and Safety of DEH113 in the Treatment of Menstrual Cramp Pain Associated With Primary Dysmenorrhea

A National, Multicenter, Randomized, Double-blind, Phase III, Crossover Clinical Trial to Assess the Efficacy and Safety of DEH113 in the Treatment of Menstrual Cramp Pain Associated With Primary Dysmenorrhea.

Last checked: Nov 19, 2026Latest source record: Feb 22, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Not yet recruiting

Enrollment

78

Planned (sponsor's estimate)

Start

Feb 2025

Primary completion

Feb 2027

Study completion Sep 2027

Sponsor

Lead sponsor
EMSIndustry
Sponsor type
Industry
First posted
Feb 20, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Crossover
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Female only, from 16 years, up to 35 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study if to evaluate the efficacy and safety of DEH113 in the Treatment of Menstrual Cramp Pain Associated With Primary Dysmenorrhea.

Conditions

  • Primary Dysmenorrhea

Interventions

  • DEH113Drug

    Tablets

  • Placebo ComparatorDrug

    Tablets

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Sum of Total Pain Relief (TOTPAR) over 0-6 hours post-doseTime frame: 6 hours post-dose

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.